KESTRA MEDICAL TECHNOLOGIES (KMTS) Stock Price, Forecast & Analysis
USA - NASDAQ:KMTS - BMG524411052 - Common Stock
KMTS Key Statistics, Chart & Performance
The current stock price of KMTS is 27.38 USD. In the past month the price increased by 10.31%.
KMTS Latest News, Press Relases and Analysis
KMTS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.77 | 215.16B | ||
| ISRG | INTUITIVE SURGICAL INC | 62.05 | 191.53B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.14 | 149.24B | ||
| SYK | STRYKER CORP | 27.05 | 136.19B | ||
| MDT | MEDTRONIC PLC | 16.4 | 116.34B | ||
| BDX | BECTON DICKINSON AND CO | 12.52 | 51.22B | ||
| IDXX | IDEXX LABORATORIES INC | 52.42 | 50.36B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.08 | 48.41B | ||
| RMD | RESMED INC | 24.94 | 36.03B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.33 | 34.22B | ||
| DXCM | DEXCOM INC | 31.3 | 22.83B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.46 | 26.31B |
Related stock screener links
About KMTS
Company Profile
Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington and currently employs 330 full-time employees. The company went IPO on 2025-03-06. The firm has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The firm's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
Company Info
KESTRA MEDICAL TECHNOLOGIES
3933 Lake Washington Blvd Ne, Suite 200
Kirkland WASHINGTON US
Employees: 330
Phone: 14252798002
KESTRA MEDICAL TECHNOLOGIES / KMTS FAQ
What does KESTRA MEDICAL TECHNOLOGIES do?
Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington and currently employs 330 full-time employees. The company went IPO on 2025-03-06. The firm has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The firm's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
What is the current price of KMTS stock?
The current stock price of KMTS is 27.38 USD. The price decreased by -2.09% in the last trading session.
Does KMTS stock pay dividends?
KMTS does not pay a dividend.
What is the ChartMill technical and fundamental rating of KMTS stock?
KMTS has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Which stock exchange lists KMTS stock?
KMTS stock is listed on the Nasdaq exchange.
Can you provide the sector and industry classification for KESTRA MEDICAL TECHNOLOGIES?
KESTRA MEDICAL TECHNOLOGIES (KMTS) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the market cap for KESTRA MEDICAL TECHNOLOGIES?
KESTRA MEDICAL TECHNOLOGIES (KMTS) has a market capitalization of 1.41B USD. This makes KMTS a Small Cap stock.
KMTS Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to KMTS.
KMTS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to KMTS. KMTS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
KMTS Financial Highlights
Over the last trailing twelve months KMTS reported a non-GAAP Earnings per Share(EPS) of -2.6. The EPS decreased by -25.08% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -48.7% | ||
| ROE | -70.43% | ||
| Debt/Equity | 0.23 |
KMTS Forecast & Estimates
12 analysts have analysed KMTS and the average price target is 27.71 USD. This implies a price increase of 1.21% is expected in the next year compared to the current price of 27.38.
For the next year, analysts expect an EPS growth of -13.42% and a revenue growth 51.29% for KMTS